From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Variable | Overall (N = 154) |
---|---|
Male – n (%) | 97 (63%) |
Age – Mean (SD) | 66.4 (10.0) |
Nationality – n (%) | |
British | 73 (47%) |
German | 56 (36%) |
Other | 25 (16%) |
Symptom severity group | |
Asymptomatic | 17 (11%) |
Mildly symptomatic | 48 (31%) |
Moderately symptomatic | 50 (33%) |
Severely symptomatic | 39 (25%) |
Number of co-morbidities present at the time of the visit – n (%) | |
None | 49 (32%) |
1 | 44 (29%) |
2 | 24 (16%) |
3+ | 37 (24%) |
Duration of MM (yrs) – Mean (SD) | 3.7 (3.7) |
Previous ASCT | 18 (12%) |